Skip to main content
. 2023 Jun 30;10(2):275–283. doi: 10.5455/javar.2023.j679

Table 3. Antibiotics sensitivity of isolated pathogens (E. coli, S. aureus, and B. cereus) from examined raw milk and dairy product samples.

Antimicrobial agenta E. coli
No. (%) of isolates (N = 60)
S. aureus
No. (%) of isolates (N = 10)
B. cereus
No. (%) of isolates (N = 30)
R (%) I (%) S (%) R (%) I (%) S (%) R (%) I (%) S (%)
AM 32 (53.3) 24 (40) 4 (6.66) 10 (100) 0 (0) 0 (0) 30 (100) 0 (0) 0 (0)
AMC 2 (3.33) 16 (26.66) 42 (70) 0 (0) 0 (0) 10 (100) NA NA NA
GM 44 (73.33) 14 (23.33) 2 (3.33) 6 (60) 4 (40) 0 (0) NA NA NA
TE 0 (0) 0 (0) 60 (100) 6 (60) 0 (0) 4 (40) 2 (6.66) 0 (0) 28 (93.33)
CTX 10 (16.66) 0 (0) 50 (83.33) 6 (60) 0 (0) 4 (40) NA NA NA
CAZ 8 (13.33) 0 (0) 52 (86.66) NA NA NA NA NA NA
C 0 (0) 10 (16.66) 50 (83.33) 0 (0) 2 (20) 8 (80) NA NA NA
CIP 0 (0) 0 (0) 60 (100) 0 (0) 0 (0) 10 (100) NAb NA NA
SXT 0 (0) 0 (0) 60 (100) 0 (0) 0 (0) 10 (100) NA NA NA
AX NA NA NA NA NA NA 6 (20) 18 (60) 6 (20)
VA NA NA NA NA NA NA 0 (0) 0 (0) 30 (100)
a

AM, ampicillin (10 μg); AMC, amoxicillin-Clavulanic A, (30 μg); AX, amoxicillin (25 μg); C, chloramphenicol (30 μg); CAZ, ceftazidime (30 μg); CIP, ciprofloxacin (5 μg); CTX, cefotaxime (30 μg); GM, gentamycin (10 μg); SXT, trimethoprim–sulfamethoxazole (25 μg); TE, tetracycline (30 μg); VA, vancomycin (30 μg).

b

NA, Not applicable.